The Problem with Bee Venom Therapy

Bee venom therapy, a controversial treatment, is used for conditions like arthritis and chronic pain. Despite historical use and some promising studies, its effectiveness remains uncertain due to small trial sizes and potential risks, including allergic reactions. The therapy involves injecting venom, often from honey bees, which contains compounds like molitin that may reduce inflammation. While some studies show benefits for inflammatory diseases and neurodegenerative conditions, the therapy's safety and efficacy need more research. The challenge lies in harnessing venom's potential while minimizing risks.

What is the primary reason some people choose to undergo bee venom therapy?

• To support bee conservation efforts

• To experience the sensation of a bee sting

• To increase their tolerance to insect venom

• To find relief from conditions like arthritis and chronic pain

How is bee venom typically administered in therapy?

• Via topical application

• Through acupuncture or intentional stings

• By inhalation

• Through oral ingestion

Which compound in bee venom is most abundant and contributes to its effects?

• Histamine

• Melittin

• Serotonin

• Dopamine

What condition has bee venom therapy shown promise in treating according to some studies?

• Hypertension

• Diabetes

• Arthritis

• Asthma

What was a significant finding of the 2018 clinical trial on bee venom therapy for Parkinson's disease?

• It caused severe allergic reactions

• It improved walking gait and quality of life

• It had no effect

• It worsened the symptoms

What is a major concern regarding the current studies on bee venom therapy?

• They focus solely on bee conservation

• They are conducted only in Europe

• They lack sufficient evidence due to small sample sizes

• They are too large and diverse

What is a well-established risk of bee venom therapy?

• It causes permanent skin discoloration

• It leads to increased bee populations

• It results in hair loss

• It can trigger severe allergic reactions